Lung microwave ablation: Post-procedure imaging features and evolution of pulmonary ground-glass nodule-like lung cancer.
Journal
Journal of cancer research and therapeutics
ISSN: 1998-4138
Titre abrégé: J Cancer Res Ther
Pays: India
ID NLM: 101249598
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
13
04
2023
accepted:
01
08
2023
medline:
2
1
2024
pubmed:
2
1
2024
entrez:
29
12
2023
Statut:
ppublish
Résumé
To retrospectively examine the imaging characteristics of chest-computed tomography (CT) following percutaneous microwave ablation (MWA) of the ground-glass nodule (GGN)-like lung cancer and its dynamic evolution over time. From June 2020 to May 2021, 147 patients with 152 GGNs (51 pure GGNs and 101 mixed GGNs, mean size 15.0 ± 6.3 mm) were enrolled in this study. One hundred and forty-seven patients underwent MWA procedures. The imaging characteristics were evaluated at predetermined time intervals: immediately after the procedure, 24-48 h, 1, 3, 6, 12, and ≥18 months (47 GGNs). This study population included 147 patients with 152 GGNs, as indicated by the results: 43.5% (66/152) adenocarcinoma in situ, 41.4% (63/152) minimally invasive adenocarcinoma, and 15.1% (23/152) invasive adenocarcinoma. Immediate post-procedure tumor-level analysis revealed that the most common CT features were ground-glass opacities (93.4%, 142/152), hyperdensity within the nodule (90.7%, 138/152), and fried egg sign or reversed halo sign (46.7%, 71/152). Subsequently, 24-48 h post-procedure, ground-glass attenuations, hyperdensity, and the fried egg sign remained the most frequent CT findings, with incidence rates of 75.0% (114/152), 71.0% (108/152), and 54.0% (82/152), respectively. Cavitation, pleural thickening, and consolidation were less frequent findings. At 1 month after the procedure, consolidation of the ablation region was the most common imaging feature. From 3 to 12 months after the procedure, the most common imaging characteristics were consolidation, involutional parenchymal bands and pleural thickening. At ≥18 months after the procedure, imaging features of the ablation zone revealed three changes: involuting fibrosis (80.8%, 38/47), consolidation nodules (12.8%, 6/47), and disappearance (6.4%, 3/47). This study outlined the anticipated CT imaging characteristics of GGN-like lung cancer following MWA. Diagnostic and interventional radiologists should be familiar with the expected imaging characteristics and dynamic evolution post-MWA in order to interpret imaging changes with a reference image.
Identifiants
pubmed: 38156934
doi: 10.4103/jcrt.jcrt_837_23
pii: 01363817-202319060-00021
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1654-1662Informations de copyright
Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209–49. doi: 10.3322/caac.21660.
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: A time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond) 2021;41:1037–48. doi: 10.1002/cac2.12197.
Ye X, Fan W, Wang Z, Wang J, Wang H, Wang J, et al. Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition). J Cancer Res Ther 2021;17:1141–56. doi: 10.4103/jcrt.jcrt_1485_21.
Huang G, Yang X, Li W, Wang J, Han X, Wei Z, et al. A feasibility and safety study of computed tomography-guided percutaneous microwave ablation: A novel therapy for multiple synchronous ground-glass opacities of the lung. Int J Hyperthermia 2020;37:414–22. doi: 10.1080/02656736.2020.1756467.
Ost D, Fein A. Management strategies for the solitary pulmonary nodule. Curr Opin Pulm Med 2004;10:272–8.
Hertzanu Y, Ye X. Computed tomography-guided percutaneous microwave ablation: A new weapon to treat ground-glass opacity-lung adenocarcinoma. J Cancer Res Ther 2019;15:265–6. doi: 10.4103/jcrt.JCRT_65_19.
Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule: A review. JAMA 2022;327:264–73. doi: 10.1001/jama.2021.24287.
Shi L, Zhao J, Peng X, Wang Y, Liu L, Sheng M. CT-based radiomics for differentiating invasive adenocarcinomas from indolent lung adenocarcinomas appearing as ground-glass nodules: A systematic review. Eur J Radiol 2021;144:109956. doi: 10.1016/j.ejrad.2021.109956.
Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. Cancer Treat Rev 2021;99:102237. doi: 10.1016/j.ctrv.2021.102237.
Chen X, Yao B, Li J, Liang C, Qi R, Yu J. Feasibility of using high-resolution computed tomography features for invasiveness differentiation of malignant nodules manifesting as ground-glass nodules. Can Respir J 2022;2022:2671772. doi: 10.1155/2022/2671772.
Shigefuku S, Shimada Y, Hagiwara M, Kakihana M, Kajiwara N, Ohira T, et al. Prognostic significance of ground-glass opacity components in 5-Year survivors with resected lung adenocarcinoma. Ann Surg Oncol 2021;28:148–56. doi: 10.1245/s10434-020-09125-x.
Meng Y, Liu CL, Cai Q, Shen YY, Chen SQ. Contrast analysis of the relationship between the HRCT sign and new pathologic classification in small ground glass nodule-like lung adenocarcinoma. Radiol Med 2019;124:8–13. doi: 10.1007/s11547-018-0936-x.
Mironova V, Blasberg JD. Evaluation of ground glass nodules. Curr Opin Pulm Med 2018;24:350–4. doi: 10.1097/MCP.0000000000000492.
Migliore M, Fornito M, Palazzolo M, Criscione A, Gangemi M, Borrata F, et al. Ground glass opacities management in the lung cancer screening era. Ann Transl Med 2018;6:90. doi: 10.21037/atm.2017.07.28.
Sihoe ADL. Should sublobar resection be offered for screening-detected lung nodules? Transl Lung Cancer Res 2021;10:2418–26. doi: 10.21037/tlcr.2020.04.06.
Lin MW, Chen JS. Image-guided techniques for localizing pulmonary nodules in thoracoscopic surgery. J Thorac Dis 2016;8(Suppl 9):S749–55. doi: 10.21037/jtd.2016.09.71.
Páez-Carpio A, Gómez FM, Isus Olivé G, Paredes P, Baetens T, Carrero E, et al. Image-guided percutaneous ablation for the treatment of lung malignancies: Current state of the art. Insights Imaging 2021;12:57. doi: 10.1186/s13244-021-00997-5.
Murphy MC, Wrobel MM, Fisher DA, Cahalane AM, Fintelmann FJ. Update on image-guided thermal lung ablation: Society guidelines, therapeutic alternatives, and postablation imaging findings. AJR Am J Roentgenol 2022;219:471–85. doi: 10.2214/AJR.21.27099.
Yang X, Ye X, Lin Z, Jin Y, Zhang K, Dong Y, et al. Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity-lung adenocarcinoma: A pilot study. J Cancer Res Ther 2018;14:764–71. doi: 10.4103/jcrt.JCRT_269_18.
Chi J, Wang Z, Ding M, Hu H, Zhai B. Technical safety and efficacy of a blunt-tip microwave ablation electrode for CT-guided ablation of pulmonary ground-glass opacity nodules. Eur Radiol 2021;31:7484–90. doi: 10.1007/s00330-021-07774-4.
Wu J, Bai HX, Chan L, Su C, Zhang PJ, Yang L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A national cancer database study. J Thorac Cardiovasc Surg 2020;160:1350–7. doi: 10.1016/j.jtcvs.2019.11.132.
Xue G, Li Z, Wang G, Wei Z, Ye X. Computed tomography-guided percutaneous microwave ablation for pulmonary multiple ground-glass opacities. J Cancer Res Ther 2021;17:811–3. doi: 10.4103/jcrt.jcrt_531_21.
Vespro V, Bonanno MC, Andrisani MC, Ierardi AM, Phillips A, Tosi D, et al. CT after lung microwave ablation: Normal findings and evolution patterns of treated lesions. Tomography 2022;8:617–26. doi: 10.3390/tomography8020051.
Araujo-Filho JAB, Menezes RSAA, Horvat N, Panizza PSB, Bernardes JPG, Damasceno RS, et al. Lung radiofrequency ablation: Post-procedure imaging patterns and late follow-up. Eur J Radiol Open 2020;7:100276. doi: 10.1016/j.ejro.2020.100276.
Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial lung abnormalities: State of the art. Radiology 2021;301:19–34. doi: 10.1148/radiol.2021204367.
Wang J, Ni Y, Yang X, Huang G, Wei Z, Li W, et al. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity. J Cancer Res Ther 2019;15:755–9. doi: 10.4103/jcrt.JCRT_399_19.
Sparchez Z, Mocan T, Hajjar NA, Bartos A, Hagiu C, Matei D, et al. Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience. Med Ultrason 2019;21:217–24. doi: 10.11152/mu-1957.
Liu S, Zhu X, Qin Z, Xu J, Zeng J, Chen J, et al. Computed tomography-guided percutaneous cryoablation for lung ground-glass opacity: A pilot study. J Cancer Res Ther 2019;15:370–4. doi: 10.4103/jcrt.JCRT_299_18.
Liu B, Ye X. Computed tomography-guided percutaneous microwave ablation: A novel perspective to treat multiple pulmonary ground-glass opacities. Thorac Cancer 2020;11:2385–8. doi: 10.1111/1759-7714.13601.
Chen J, Lin XN, Miao XH, Chen J, Lin RX, Su HY, et al. Evaluation of the correlation between infrared thermal imaging-magnetic resonance imaging-pathology of microwave ablation of lesions in rabbit lung tumors. J Cancer Res Ther 2020;16:1129–33. doi: 10.4103/0973-1482.296428.
Lin R, Fang Y, Chen J, Lin Q, Chen J, Yan Y, et al. MR-guided microwave ablation for lung malignant tumor: A single center prospective study. Front Oncol 2022;12:856340. doi: 10.3389/fonc.2022.856340.
Shang Y, Li G, Zhang B, Wu Y, Chen Y, Li C, et al. Image-guided percutaneous ablation for lung malignancies. Front Oncol 2022;12:1020296. doi: 10.3389/fonc.2022.1020296.
Frandon J, Akessoul P, Kammoun T, Dabli D, de Forges H, Beregi JP, et al. Microwave ablation of liver, kidney and lung lesions: One-month response and manufacturer’s charts’ reliability in clinical practice. Sensors (Basel) 2022;22:3973. doi: 10.3390/s22113973.
Chheang S, Abtin F, Guteirrez A, Genshaft S, Suh R. Imaging features following thermal ablation of lung malignancies. Semin Intervent Radiol 2013;30:157–68. doi: 10.1055/s-0033-1342957.
Ahrar K, Tam AL, Kuban JD, Wu CC. Imaging of the thorax after percutaneous thermal ablation of lung malignancies. Clin Radiol 2022;77:31–43. doi: 10.1016/j.crad.2021.07.007.
Ye X, Fan W, Wang Z, Wang J, Wang H, Niu L, et al. Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition). J Cancer Res Ther 2022;18:1213–30. doi: 10.4103/jcrt.jcrt_880_22.
Liu B, Li C, Sun X, Zhou W, Sun J, Liu H, et al. Assessment and prognostic value of immediate changes in post-ablation intratumor density heterogeneity of pulmonary tumors via radiomics-based computed tomography features. Front Oncol 2021;11:615174. doi: 10.3389/fonc.2021.615174.
Alberti N, Buy X, Frulio N, Montaudon M, Canella M, Gangi A, et al. Rare complications after lung percutaneous radiofrequency ablation: Incidence, risk factors, prevention and management. Eur J Radiol 2016;85:1181–91. doi: 10.1016/j.ejrad.2016.03.032.
Wei Z, Ye X, Yang X, Huang G, Li W, Wang J, et al. Advanced non small cell lung cancer: Response to microwave ablation and EGFR Status. Eur Radiol 2017;27:1685–94. doi: 10.1007/s00330-016-4474-4.
Wei Z, Ye X, Yang X, Zheng A, Huang G, Li W, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol 2015;38:135–42. doi: 10.1007/s00270-014-0895-0.
Wei Z, Ye X, Yang X, Huang G, Li W, Han X, et al. Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: A retrospective study. Int J Hyperthermia 2019;36:827–34. doi: 10.1080/02656736.2019.1642522.
Wei Z, Yang X, Ye X, Feng Q, Xu Y, Zhang L, et al. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: A multicenter, randomized, controlled, phase III clinical trial. Eur Radiol 2020;30:2692–702. doi: 10.1007/s00330-019-06613-x.
Yang X, Ye X, Zhang L, Geng D, Du Z, Yu G, et al. Microwave ablation for lung cancer patients with a single lung: Clinical evaluation of 11 cases. Thorac Cancer 2018;9:548–54. doi: 10.1111/1759-7714.12611.
Watson RA, Tol I, Gunawardana S, Tsakok MT. Is microwave ablation an alternative to stereotactic ablative body radiotherapy in patients with inoperable early-stage primary lung cancer? Interact Cardiovasc Thorac Surg 2019;29:539–43. doi: 10.1093/icvts/ivz123.